Literature DB >> 20345143

Synthetic studies of tamandarin B side chain analogues.

Kenneth M Lassen1, Jisun Lee, Madeleine M Joullié.   

Abstract

The syntheses of three tamandarin B analogues are described. The goal of these studies was to prepare material to determine their relative therapeutic index and to gain an oversight as to their potential for clinical applications.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20345143      PMCID： PMC2862102          DOI： 10.1021/jo100457w

Source DB:  PubMed          Journal:  J Org Chem        ISSN： 0022-3263            Impact factor:   4.354


  29 in total

1.  Synthesis and biological evaluation of didemnin photoaffinity analogues.

Authors:  M D Vera; A J Pfizenmayer; X Ding; D Ahuja; P L Toogood; M M Joullié
Journal:  Bioorg Med Chem Lett       Date:  2001-07-23       Impact factor: 2.823

2.  Total synthesis of [(2S)-Hiv2]didemnin M.

Authors:  B Liang; M D Vera; M M Joullié
Journal:  J Org Chem       Date:  2000-07-28       Impact factor: 4.354

3.  Restricted conformation analogues of an anthelmintic cyclodepsipeptide.

Authors:  Fred E Dutton; Byung H Lee; Sandra S Johnson; Eileen M Coscarelli; Pil H Lee
Journal:  J Med Chem       Date:  2003-05-22       Impact factor: 7.446

Review 4.  Bioactive compounds from aquatic and terrestrial sources.

Authors:  K L Rinehart; T G Holt; N L Fregeau; P A Keifer; G R Wilson; T J Perun; R Sakai; A G Thompson; J G Stroh; L S Shield
Journal:  J Nat Prod       Date:  1990 Jul-Aug       Impact factor: 4.050

5.  Synthetic Routes to a Constrained Ring Analog of Didemnin B.

Authors:  Scott C. Mayer; Amy J. Pfizenmayer; Madeleine M. Joullié
Journal:  J Org Chem       Date:  1996-03-08       Impact factor: 4.354

6.  Total syntheses and biological investigations of tamandarins A and B and tamandarin A analogs.

Authors:  B Liang; D J Richard; P S Portonovo; M M Joullié
Journal:  J Am Chem Soc       Date:  2001-05-16       Impact factor: 15.419

7.  Synthesis, conformational analysis, and cytotoxicity of conformationally constrained aplidine and tamandarin A analogues incorporating a spirolactam beta-turn mimetic.

Authors:  Marta Gutiérrez-Rodríguez; Mercedes Martín-Martínez; M Teresa García-López; Rosario Herranz; Félix Cuevas; Concepción Polanco; Ignacio Rodríguez-Campos; Ignacio Manzanares; Francisco Cárdenas; Miguel Feliz; Paul Lloyd-Williams; Ernest Giralt
Journal:  J Med Chem       Date:  2004-11-04       Impact factor: 7.446

8.  Antiproliferative effect of dehydrodidemnin B (DDB), a depsipeptide isolated from Mediterranean tunicates.

Authors:  J L Urdiales; P Morata; I Núñez De Castro; F Sánchez-Jiménez
Journal:  Cancer Lett       Date:  1996-04-19       Impact factor: 8.679

9.  Aplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4.

Authors:  M Broggini; S V Marchini; E Galliera; P Borsotti; G Taraboletti; E Erba; M Sironi; J Jimeno; G T Faircloth; R Giavazzi; M D'Incalci
Journal:  Leukemia       Date:  2003-01       Impact factor: 11.528

10.  Antineoplastic activity of didemnin congeners: nordidemnin and modified chain analogues.

Authors:  P Jouin; J Poncet; M N Dufour; A Aumelas; A Pantaloni; S Cros; G François
Journal:  J Med Chem       Date:  1991-02       Impact factor: 7.446
View more
  2 in total

1.  Total synthesis of Lys(3) tamandarin M: a potential affinity ligand.

Authors:  Kenneth M Lassen; Madeleine M Joullié
Journal:  Org Lett       Date:  2010-10-29       Impact factor: 6.005

Review 2.  "Head-to-side-chain" cyclodepsipeptides of marine origin.

Authors:  Marta Pelay-Gimeno; Judit Tulla-Puche; Fernando Albericio
Journal:  Mar Drugs       Date:  2013-05-21       Impact factor: 5.118
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.